The complement system is a cascade of serum proteins and receptors which forms a vital arm of innate immunity and enhances the adaptive immune response. This work establishes the chromosomal localization of four key genes of the murine complement system. Mapping was performed using a novel and rapid PCR restriction length polymorphism method which was developed to exploit the murine expressed sequence tag (EST) database. This technique circumvents the laborious cDNA or genomic cloning steps of other mapping methods by relying on EST data and the prediction of exon-intron boundaries. This method can be easily applied to the genes of other systems, ranging from the interests of the individual researcher to large-scale gene localization projects. Here the complement system, probably one of the most well-characterized areas of immunology, was used as a model system. It was shown that the C3a receptor C1r and C1s genes form an unexpected complement gene cluster towards the telomeric end of chromosome 6. The second mannose binding lectin-associated serine protease gene was mapped to the telomeric end of chromosome 4, which is distinct from other complement-activating serine proteases. These results provide new insights into the evolution of this group of proteins.
Introduction
The complement system acts as a vital part of the innate targets which lead to activation. The key recognition protein of the classical pathway is C1q, which recognizes antigenimmune system, generating several mechanisms of immune protection (1) and complementing the adaptive clonal aggregated antibody. Complement activation then proceeds through the enzymatic action of the C1q-associated serine immune system (2). It also influences how the adaptive immune response is established (3). This highly reactive and proteases, C1r and C1s (4). The MBLectin pathway (5) allows the recognition of carbohydrate structures on potential potentially destructive arm of immunity contains regulatory components which normally prevent overactivation of the pathogens via mannan-binding lectin (MBL) and constitutes what may be the most ancient pathway of complement system. Activation proceeds through three different pathways. Firstly, a constitutive background activation is fostered by activation, predating adaptive immunity (6). Activation through the MBLectin pathway is brought about via the MBL-associthe alternative pathway, amplifying the gentle 'tick-over' of complement activation. In the presence of activating ated serine proteases, MASP1 and MASP2, in a similar fashion to that seen in the C1 complex (7). Together all four of the surfaces the complement cascade proceeds because activating complexes escape the control of the regulatory associated serine proteases form a unique branch of the serine protease superfamily (6,8,9). proteins that suppress activation. The remaining two pathways, i.e. the classical and MBLectin pathways, both utilize Two anaphylatoxin receptors, the C3a and C5a receptors (C3aR and C5aR), are present in the complement system and the same underlying machinery of the complement cascade, differing only in the recognition molecules used and the respond to fragments of the complement cascade generated during activation. This family of G protein-coupled, seventransmembrane spanning proteins all act as chemoattractant receptors. Triggering of the two complement receptors is essential for eliciting various inflammatory reactions mediated by complement, such as the induction of smooth muscle contraction, increasing vascular permeability, directing the migration of phagocytic cells and inducing histamine release. These in turn enhance the adaptive immune response, as emphasized by the findings from C5aR knockout mice (10, 11) . The gene for C5aR is located in a cluster with other chemoattractant receptors on human chromosome 19q13.3-q13.4 (12) . However, the gene for C3aR encodes for a receptor with an uniquely large second extracellular loop (13) that has a distinct localization, outside the chemoattractant gene cluster, on human chromosome 12p12-p13.3 (14, 15) . From the complement gene localizations carried out to date, in humans and mice, there are three major gene clusters that have been described which account for many of the 40 genes which encode for the complement system proteins. First, the regulator of complement activation (RCA) gene cluster forms a linkage group for many of the complement proteins which control the activation and degradation of C3 and C4 (16) . Second, some of the key early components of two isotypes of C4, C4A and C4B (17) . The third cluster A key for the figure is shown below.
constitutes some of the complement components of the membrane attack complex; C6, C7 and C9 (18) . The three other complement gene arrays represent duplications, C1s cases with the human homologues of these cDNAs, using and C1r (19) ; two of the genes which encode C8, C8A and BLAST 2.0 (NCBI). The ESTs were aligned against the human C8B (20); and the three genes which encode for the A, B homologues using Seqman (DNAstar, London, UK), then and C polypeptide chains of C1q (21) .
adjusted by eye. All alignments of the partial cDNA sequences This paper describes for the first time a rapid technique derived from murine ESTs showed between 74.6 and 80.2% for genetically mapping mouse genes without the laborious identity at the nucleotide level with the human counterparts. process of cDNA or genomic cloning. This method allows the In the case of MASP1, primers were designed from the known chromosomal assignment of genes without requiring large murine cDNA sequence, accession no. D16492 (22) . For amounts of DNA for use in hybridization nor the need for each gene, the intron-exon boundaries were predicted from fluorescent in situ hybridization (FISH) expertise and equipeither the human gene structure of MASP1 (23) and C1s (24) ment. By using expressed sequence tags (EST) as tools for or in the case of Masp2 and C1r by predicting intron-exon rapid gene localization, it allows the mapping of genes, which boundaries from the known protein module architecture. are known to be expressed, onto the European Collaborative Alternatively, gene structures from other species could also Interspecific Backcross (EUCIB) genetic map. This enhances be used for this prediction. Primers were designed to generate the information content of genetic maps, which are mainly PCR products which spanned two predicted exons and the composed of anonymous markers of nucleotide repeats that intervening intron. Introns that were between 1 and 2 kb in generally have no known gene association. This technique has size were chosen for amplification. EST from dbEST that been used for the chromosomal mapping of four complement covered a suitable exon-intron boundary chosen for ampligenes and has shed light upon the molecular evolution of the fication of the genes for Masp2, C1r and C1s were AA895155, MASPs/C1s/C1r family from the chromosomal distribution of AA427242 and AA798057 respectively (see Fig. 1 ). However, these genes in the mouse, and has also uncovered an for C3aR, the murine gene sequence was known (14, 25, 26 The conditions of the PCR are listed including the PCR program which shows the length of time (in s) for each step in the PCR: the denaturation step followed by the annealing step and the extension time. The enzyme used for detecting the polymorphism is shown, along with expected allele sizes. T m indicates the melt temperature used for each primer. MS and B6 indicates M.spretus and C57BL/6 respectively. generate a single distinct product (see Table 1 ). The PCR purification in a 20 µl restriction digestion using 10 U of each enzyme. The presence of restriction polymorphisms was then was performed on genomic DNA samples from the two different inbred mouse species (C57BL/6 and Mus spretus).
judged by running the digestion products on a 1% (w/v) agarose gel and comparing the two different alleles. An ApaLI PCR was carried out for 30 cycles of amplification, 94°C denaturation for 30 s, 30 s at the optimized annealing polymorphism was found in the C3aR gene, Masp2 has a XhoI polymorphism, and both C1s and Masp1 have a Bsu36I temperature for each set of primers, followed by a 72°C extension of 1 or 2 min (shown in Table 1 ). The program polymorphism, while an AvaII polymorphism was found in the gene for C1r. The same restriction fragmentation pattern was finished with a final 5 min elongation reaction at 72°C. Genomic DNA (25 ng) was used in a 20 µl PCR mixture seen with both the purified PCR product and the unpurified PCR product. The polymorphisms identified in the PCR containing 16 mM (NH 4 ) 2 SO 4 , 67 mM Tris-HCl, pH 8.8, 0.01% (v/v) Tween 20, 1 U Taq DNA polymerase, 200 µM each dNTP products of these complement genes were then used for genetic mapping of those loci. and 0.25 µM each primer supplemented with either 1.25 or 1.5 mM MgCl 2 (see Table 1 ). Part of the reaction product Chromosomal localization (10 µl) was run on a 1% (w/v) agarose gel and visualized by ethidium bromide staining.
A random selection of genomic DNA from 50 backcross mice of the EUCIB panel (Human Genome Mapping Project
Subcloning and sequence confirmation of the PCR products
Resource Centre, Cambridge, UK) (27) was used for mapping.
used for localization
All the animals used were from a C57BL/6ϫM. spretus F 1 generation backcrossed with either parental species. For fineThe identity of the PCR products used in genetic mapping was confirmed by sequencing. The PCR product was first scale mapping, panels of informative recombinant mice were analysed for each gene. The inheritance of each allele was cloned into a 3Ј-deoxythymidine residue overhang plasmid (pCRII-TOPO; Invitrogen, Groningen, The Netherlands) assessed by the PCR-based restriction polymorphism described above. The results were used to determine both following the manufacturer's instructions. For each gene of interest, one plasmid bearing the amplified section of the the chromosomal location and the fine-scale mapping position of the gene, with respect to other known EUCIB markers on gene was selected for sequence analysis. Fluorescent dye-primer cycle sequencing with AmpliTaq FS (ABI Prism; the mouse genome. Perkin-Elmer, Warrington, UK) was used to confirm the identity PCR cloning of the MASP2 serine protease domain of the PCR product.
Murine ESTs from dbEST were aligned across the part of the Screening for restriction polymorphisms cDNA sequence encoding the serine protease domain of human MASP2. All ESTs identified by database screening For genetic mapping of the gene of interest using backcross mice, the different parental alleles were monitored by the were aligned using the human sequence as reference. The translated murine protein sequence of the Masp2 serine restriction fragmentation length polymorphisms (RFLP) contained within the PCR product of the gene of interest. The protease domain shared an identity of 79.9 and 76.1% with that of human MASP2 protein and cDNA respectively. Primers, RFLP between the two mouse species were discovered by screening with 30 different restriction enzymes (New MM2-1f (AAC AGC CGC TCA TGC TGT ATA TGA G) and MM2-2r (CCC CAC TGT CAC CTC TGC AGC TGT C), were England Biolabs, Hitchin, UK) that each had 5 or 6 bp recognition sites. For speed and minimal experimental designed from the 5Ј and 3Ј cDNA extent of the murine Masp2 serine protease domain, based on the sequences of manipulations, 10 µl of the PCR product generated from the different mice was used directly from the PCR without the murine ESTs (AA244853 and AA530523 respectively).
PCR was carried out on~25 ng of genomic DNA from a M. chromosomal region 12p12-p13.3 which contains the Spretus mouse, using the PCR conditions described above, human genes for C1r and C1s (28) . The human genes have except the primers MM2-1f and MM2-2r were used. This been shown to be in close proximity, arranged in a tail-to-tail reaction was optimized to 1 mM MgCl 2 , an annealing temperfashion (19) . ature of 59°C and an extension time of 90 s. The single,
The murine gene for the complement C3a anaphylatoxin discrete PCR product of~500 bp was cloned into PCRIIreceptor, C3aR, has recently been localized to region F1 on TOPO. Two of the plasmid clones were sequenced with both chromosome 6 (14), a region which is syntenic to an area on vector and internal primers by fluorescent cycle sequencing, the short arm of human chromosome 12. This region, 12p13.2, and it was confirmed that they containing the entire cDNA for contains the human genes for C1r and C1s (28) . To examine the murine Masp2 serine protease domain.
whether these genes formed an unexpected cluster at the genetic level or merely localized to the same chromosomal band, murine C3aR was also mapped onto the EUCIB genetic Results map. Initial mapping showed that C3aR localized to a region of chromosome 6, with a LOD score of 7.12, which confirmed Development of RFLP in situ hybridization data (14) . Genetic mapping data also Primers were designed to generate a PCR product from each suggested a localization for C3aR which was close to C1r gene (Masp1, Masp2, C1r and C1s) which spanned two and C1s. Fine-scale mapping showed that C3aR coexons and a intervening intron. The position of the introns segregates with C1s and C1r, to a segment of DNA that were predicted, in these cases, from the human gene structure spans~0.17 cM, between the markers D6Mit24 and D6Mit337 or from conserved intron-exon boundaries within protein towards the telomeric end of chromosome 6, at~65 cM from modules. Alternatively, gene structures from other species the centromere. could be used. Introns were chosen which were 1-2 kb in length to facilitate amplification of a single PCR product with
The intron-exon boundary of the serine protease domain sufficient yield for visualization. In the case of C3aR where of MASP2 the gene and cDNA sequences were known, an~650 bp segment of the 5Ј region of the gene including 200 bp of Alignment of murine EST with the human sequence for MASP2 exonic sequence was amplified since the only intron was revealed several EST which spanned the serine protease Ͼ4 kb in length. Intronic DNA was chosen for amplification, domain. The resulting coding sequence for the serine protease since it is more divergent than exonic DNA between different domain of murine Masp2 was initially used for developing a species and strains, hence it was assumed to be a potent PCR-RFLP by predicting intron-exon boundaries from the source of RFLP between the two species of mice used in human MASP1 gene (23) . PCR across this region revealed a backcross analysis (C57BL/6 and M. spretus). Amplification surprising feature of the murine Masp2 gene. PCR with two products were designed to include at least 200 bp of exonic independent primer pairs across two predicted Masp2 introns DNA. This was used to confirm, by sequencing analysis, that yielded products from genomic DNA that were of the same the correct gene was being amplified from the murine genome.
size as the EST assembled murine cDNA sequence (results The PCR products for each gene gave a discrete single not shown). This suggested that the serine protease domain band, and these were subcloned and sequenced. The DNA of murine Masp2 is encoded by a single uninterrupted exon, sequence was in agreement with either the known gene similar to the gene structures of C1s and C1r (24), which is sequence (C3aR) or of the murine EST, confirming that the quite distinct from the six exon arrangement of the serine PCR was specific for the gene of interest (results not shown).
protease domain of human MASP1 (23) . To further underThe sequences which were interrupted by introns, had stand this finding, the entire serine protease encoding region boundaries which conformed to the GT-AG rule.
of Masp2 was cloned by PCR from murine genomic DNA. The use of 30 different restriction enzymes with either 5 or PCR primers were designed at the 5Ј and 3Ј end of the 6 bp recognition sites generally produced one or two RFLP, serine protease domain from murine EST (AA244853 and between the two alleles. An RFLP was chosen if it could be AA530523) and produced a PCR product of the expected clearly distinguished on a 1% (w/v) agarose gel. Details of size~625 bp, as predicted from the cDNA sequenced the enzymes used for each gene and the allele sizes for each generated by alignment of Masp2 EST. This product was species are detailed in Table 1 , and examples of the restriction subcloned into a 3Ј deoxythymidine residue overhang vector pattern observed for parental and heterozygous animals are (pCRII-TOPO). All of the 12 clones tested were of the correct shown at the top of Fig. 2 . size, as judged by agarose gel electrophoresis. Sequencing Chromosomal localization of C1r, C1s and C3aR of one clone showed identity to the DNA sequence of Masp2 generated from EST (results not shown), with a 79.9% identity Using a random panel of 50 backcross mice, C1r and C1s to the protease domain of human MASP2 at the protein were shown to map to the telomeric end of chromosome 6
level. This confirmed that the PCR product was the murine with LOD scores of 6 and 9.7 respectively. Fine-scale mapping homologue of human MASP2 and that the genomic region of mice with informative recombinants in the region D6Mit24-encoding the serine protease domain of murine gene for D6Mit14 revealed that C1s and C1r co-segregated between MASP2 did not contain introns. An intron-less encoded serine the markers D6Mit24 and D6Mit337, at a position~65 cM protease domain was also observed by PCR across the from the centromere. This region of murine chromosome 6 containing the genes for C1r and C1s is syntenic with human human MASP2 gene (results not shown). 
Chromosomal localization of Masp2 selection of only 50 mice, Masp1 was clearly shown to map to the telomeric tip of chromosome 16 (results not shown). A PCR-RFLP was developed which extended across the two
This explicitly shows that, unlike the C1q-associated serine exons that encode the first complement control protein domain proteases, C1r and C1s, the MBL-associated serine proteases in murine Masp2. The murine Masp2 gene was mapped to do not form a linkage group, and in fact map to different chromosome 4 with a LOD score of 6.28. Fine-scale mapping chromosomes in mice and probably in humans. with mice recombinant between D4Mit179 and D4Nds16, showed that Masp2 maps to the 0.11 cM region between D4Mit48 and D4Mit160, at the telomeric end of chromosome Discussion 4, 75 cM from the centromere. The chromosomal localization of Masp2 is distinct from that observed for Masp1, where This paper describes the first use of a novel and rapid method of localizing murine genes onto a genetic map by utilizing Masp1 has been shown by FISH to map to the B2-B3 region of mouse chromosome 16 (29) . This was confirmed by data from the murine EST project. This method has been successfully used to rapidly assign high-resolution chromolocalizing the gene onto the EUCIB genetic map using a PCR-RFLP that was developed to Masp1. Using a random somal localizations for four complement genes. This method Genes belonging to the three complement gene clusters are identified by the following superscript symbols: a MHC class III complement gene cluster, b RCA gene cluster (however, mice have two Daf genes which are located outside the RCA gene cluster) and c membrane attack complex (MAC) gene cluster. Entries shown in bold highlight the murine genes which were mapped by this study. Alternative splicing of the gene Cr2 generates two gene products with homology to the human complement receptors, CR1 and CR2, while Crry is considered to be the evolutionary homologue of human CR1 at the genetic level.
does not rely upon technical expertise or reagents that are morphisms, which is only a potential drawback with single exon genes, or in genes with small introns, where less frequent not commonly found in most molecular biology laboratories. More importantly it does not require cloning of the genes or untranslated and coding region polymorphisms are relied upon. Care must also be taken in the identification of genes cDNAs. Instead, this technique relies upon the availability of murine EST generated from this large-scale sequencing across species due to the possibility of gene duplication and the existence of pseudogenes. project. One potential drawback of this method is finding relevant EST information for the gene of interest; however, On searching for protein systems in which the murine genes have not been identified or localized, but where murine EST the large-scale murine EST sequencing effort has already provided information amassed over 650,000 sequences exist, the complement system was identified as an ideal candidate for testing this new method upon (see Table 2 ). (dbEST release 070999) and over the next few years it will provide sequence information on the vast majority expressed Herein, the chromosomal localization of four complement genes has been assigned by this rapid localization method genes (30). The second difficulty in using this method is the prediction of introns, but with the constant release of improving and an unexpected clustering of these genes has been revealed. The murine genes for C1r and C1s map well to the genome-EST alignment software (31) , and the expanding genetic knowledge of protein modules and gene structures telomeric end of chromosome 6, at~65 cM, with LOD scores of 6.0 and 9.7 respectively. This region of the mouse genome from humans and other species, this decision process is relatively simple. A third limitation is uncovering polyis syntenic with human chromosome 12p13 which contains the two linked human genes for C1r and C1s (29). Recent mapping of the murine C3aR gene to chromosome 6 band F1 (14), a broad region that encompasses C1r and C1s, provoked the idea that C3aR may map to this cluster. This idea was tested quickly by developing a PCR-RFLP to C3aR. Mapping showed that C3aR localized to the same region as C1r and C1s on chromosome 6, and fine-scale mapping revealed that the three genes were linked and that C3aR cosegregates with C1r and C1s in an~0.17 cM segment of the murine genome. This is an unexpected complement gene cluster because within the other complement gene clusters all the genes share high sequence homology with each other (Table 2 : the RCA cluster, C2 and factor B of the MHC class III cluster, the MAC cluster, the C1q chain genes and the C8 genes). C3aR is very distinct from C1r and C1s at the protein sequence level and even at the gene level, C3aR has a single structural exon while C1r and C1s have dispersed structural genes covering several exons. Comparison of the recent FISH mapping for the human C3aR gene to 12p13.2-12p13.3 (14, The C1r and C1s genes in humans (19) and mice (shown could be expected to be linked. Alternatively, Masp2 could localize with C1r and C1s, as expected from their similarity at the genomic level: the intron-less state of their serine protease domains, shown here for Masp2 (Fig. 3A) and also the elegant symmetry seen between the MBLectin and Classical pathways (for review, see 1,7). After auto-activation from the conserved functional elements in the serine protease regions, see below (Fig. 3B) . Genetic mapping of Masp2 by of C1r, via C1q binding to clustered antibodies, C1r activates the serine protease activity of C1s. C1s proceeds to cleave developing a PCR-RFLP (Fig. 2B, top) revealed that Masp2 maps to chromosome 4 with a LOD score of 6.28. Fine-scale the first two components of the classical pathway, C4 followed by C2. The resulting complex, composed of activated C4 and mapping of informative recombinants (Fig. 2B , middle and bottom) indicates that the murine gene lies in an~0.11 cM C2, is the classical pathway C3 convertase. In contrast, despite the MBLectin pathway impinging on the same key region of DNA towards the telomeric end of chromosome 4, between D4Mit48 and D4Mit160. Masp2 localizes to a different components and forming an identical classical pathway C3 convertase, the functions of the MASPs cannot be superposition to its partner MBL-associated serine protease, Masp1, which localizes to the telomeric region of murine imposed onto those C1r and C1s. The activation process involving the MASPs appears far more complex. MASP2 has chromosome 16, region B2-B3, by FISH (35) and by genetic mapping described herein. The non-association of the two been reported to have a similar substrate specificity to that of C1s, cleaving both C4 (7) and C2 (36), but may also MBL-associated serine proteases genes, Masp1 and Masp2, is in marked contrast to the position and clustering of the two possess an auto-activation capacity (37), whereas MASP1 has been shown to cleave C2 (36) and perhaps C3, thus C1q-associated serine proteases genes, C1r and C1s.
The chromosomal positions of the MASP genes discount circumventing the action of the classical pathway C3 convertase (8, 38, 39) . The cleavage of C3 by MASP1 remains the idea that C1r and C1s arose through a simple duplication of the more ancient MASP genes. This is highlighted at the controversial, as it cannot be confirmed by others (40). It is clear from phylogenetic analysis that MASP1 and functional level where human MASP1 and MASP2 do not appear to be functional analogues of C1r and C1s, despite MASP2/C1r/C1s form divergent arms of the serine protease family of the complement system (6,8,9). This is echoed at site serine is encoded by a TCN codon, which is TCT in mice, while MASP2/C1r/C1s are AGY types, with the active site many different levels (see Fig. 3 ). The functional elements of the serine protease domain, which support the evolutionary serines being encoded respectively by AGT, AGT and AGC in mice. The histidine loop, typical of MASP1, is present in theory of Endo et al. (9) , are important for clarifying that the EST identified are the murine counterparts of the human the murine Masp1, and absent in the murine Masp2, C1r and C1s. The residue, 3 amino acids C-terminal to the active site sequences. MASP1 is a TCN serine protease, since the active serine, is a proline in murine MASP1, which is generally localization data gene structures and phylogenetic studies of others, helps explain the different chromosomal and exon conserved in chymotrypsinogen-like proteases but replaced with a valine or an alanine in MASP2/C1r/C1s (see Fig. 3B ).
arrangements of the two lineages of MBL/C1q-associated serine proteases. The idea of the two lineages of MASP/C1r/C1s (9) is reflected at the genetic level.
The intron-exon organization of Masp1 displays a type of Data deposition split exon arrangement for the serine protease domain (23), which is not seen in other serine protease genes (41,42). The
The complete linkage data is available from the EUCIB serine protease domains of Masp2, C1r and C1s are, however, home page (http://www.hgmp.mrc.ac.uk/MBx/MBxHomeencoded by single exons, as seen in the non-functional serine page.html). protease, haptoglobin (43) . The exon arrangement of the serine protease domains, taken together with the chromosomal localizations, allows speculation as to the evolution of Acknowledgements these proteins (Fig. 4) . The parsimonious answer, based on evolutionary history (44) and two different mechanisms have been proposed (44, 45) . The idea of RNA-mediated gene duplication or intron loss occurring during gene family evoluReferences tion is well documented (41,46). Therefore, this would leave an ancestral MASP2/C1r/C1s-like gene and an ancestral
